L. Sammaritano

A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome.

M. Peterson, M. Lockshin, L. Sammaritano, 2002, Rheumatology.

Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome

N. Costedoat-Chalumeau, V. Guern, E. Hachulla, 2018, Lupus.

Antiphospholipid Antibodies Activate Vascular Endothelial Cells

L. Sammaritano, J. Salmon, R. Silverstein, 1996, Lupus.

Grand rounds from International lupus centres CLINICO-PATHOLOGICAL CONFERENCE

S. Goodman, L. Sammaritano, E. Dicarlo, 1997 .

Significance of aPL IgG Subclasses

L. Sammaritano, 1996, Lupus.

Moderate versus high-titer persistently anticardiolipin antibody positive patients: Are they clinically different and does high-titer anti-β2-glycoprotein-I antibody positivity offer additional predictive information?

M. Barbhaiya, M. Lockshin, D. Erkan, 2010, Lupus.

Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome.

A. Tincani, A. Lojacono, M. Lockshin, 1994, The Journal of rheumatology.

Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H).

K. Elkon, L. Sammaritano, A. Gharavi, 1992, The Journal of clinical investigation.